Literatur
- 1 McCullough P. Psychotherapie der chronischen Depression. Cognitive Behavioral Analysis
System of Psychotherapy - CBASP. München, Jena; Urban & Fischer 2006
- 2 Klerman G L, Weissman M M, Rounsaville B J, Chevron E S. Interpersonal psychotherapy
of depression. New York; Basic Books Inc., Publisher 1984
- 3 Schramm E (Hrsg). Interpersonelle Psychotherapie bei Depressionen und anderen psychischen
Störungen. Stuttgart; Schattauer 1998
- 4
Markowitz J C.
Interpersonal psychotherapy for chronic depression.
JCLP.
2003;
59
847-858
- 5 Schramm E.
Interpersonelle Psychotherapie bei chronischen Depressionen. In: Bschor T (Hrsg) Behandlungsmanual therapieresistente Depression. Stuttgart; Kohlhammer
2008 (im Druck)
- 6 Beck A T, Rush A J, Shaw B F, Emery G. Kognitive Therapie der Depression. Weinheim;
Beltz PVU 1996
- 7 Lewinson P M.
A behavioral approach to depression. In: Friedmann RJ, Katz MM (eds) The psychology of depression. New York; Wiley 1974
- 8 AHCPR Agency for Health Care Policy and Research .Clinical Practice Guideline No.
1. AHCPR Publication 1993 No. 92-0023
- 9
Ravindran A V, Anismen H, Merali Z. et al .
Treatment of primary dysthymia with group cognitive therapy and pharmacotherapy: clinical
symptoms and functional impairments.
Am J Psychiatry.
1999;
156
1608-1617
- 10
Markowitz J C, Kocsis J H, Bleiberg K L. et al .
A comparative trial of psychotherapy and pharmacotherapy for „pure” dysthymic patients.
J Affect Dis.
2005;
89
167-175
- 11
Browne G, Steiner M, Roberts J. et al .
Sertraline and/or interpersonal psychotherapy for patients with dysthymic disorder
in primary care: 6-month comparison with longitudinal 2-year follow-up of effectiveness
and costs.
J Affect Dis.
2002;
68
317-330
- 12
Dunner D I, Schmaling K B, Hendrickson H. et al .
Cognitive therapy versus fluoxetin in the treatment of dystymic disorder.
Depression.
1996;
4
34-41
- 13
deMello M F, Myczcowsk L M, Menezes P R.
A randomized controlled trail comparing moclobemid and moclobemid plus interpersonal
psychotherapy in the treatment of dysthymic disorder.
J Psychother Pract Res.
2001;
10
117-123
- 14
Hellerstein D J, Little S AS, Samstag L W. et al .
Adding group psychotherapy to medication treatment in dysthymia. A randomized prospective
pilot study.
J Psychother Pract Res.
2001;
10
93-103
- 15
Agosti V, Ocepek-Wwelikson K.
The efficacy of imipramine and psychotherapy in early-onset chronic depression: a
reanalysis of the National Instiute of Mental Health Treatment of Depression Collaborative
Research Program.
J Affect Dis.
1997;
43
181-186
- 16
Keller M B, McCullough J P, Klein D N. et al .
A comparison of Nefazodon, the Cognitive Behavioral-Analysis System of Psychotherapy,
and their combination for the treatment of chronic depression.
N Engl J Med.
2000;
342
1462-1470
- 17
Miller I W, Norman W H, Keitner G I.
Combined treatment for patients with double depression.
Psychother Psychosom.
1999;
68
180-185
- 18
Schramm E, Schneider D, Zobel I. et al .
Efficacy of interpersonal psychotherapy plus pharmacotherapy in chronically depressed
inpatients.
J Affect Disord.
2008 (im Druck);
- 19
Schatzberg A F, Rush A, Arnow B A. et al .
Chronic depression. Medication (Nefazodon) or psychotherapy (CBASP) is effective when
the other is not.
Arch Gen Psychiatry.
2005;
62
513-520
- 20
Kocsis J H, Rush A J, Markowitz J C. et al .
Continuation treatment of chronic depression: a comparison of Nefazodon, Cognitive
Behavioral Analyssis System of Psychotherapy, and their combination.
Psychopharmacol Bull.
2003;
37
73-87
- 21
Perlis R H, Nierenberg A A, Alpert J E. et al .
Effects of adding cognitive therapy to fluoxetine dose increase on risk of relapse
and residual depressive symptoms in continuation treatment of major depressive disorder.
J Clin Psychopharmacol.
2002;
22
474-480
- 22
Klein D N, Arnow B A, Blalock J A. et al .
Cognitive-Behavioral Analysis System of Psychotherapy as a maintenance treatment for
chronic depression.
J Consult Clin Psychol.
2004;
72
681-688
Dr. Heide Hecht
Universitätsklinikum Freiburg
Abt. für Psychiatrie und Psychotherapie
Hauptstraße 5
79104 Freiburg
eMail: Heidemarie.Hecht@uniklinik-freiburg.de